Home
Nacuity Pharmaceuticals, Inc. is a clinical stage biotech focused on treatment of ocular oxidative stress.
Home
Initial focus to develop a breakthrough treatment for retinitis pigmentosa (RP).
Home
Technology based on studies from the laboratory of Dr. Peter Campochiaro, Wilmer Eye Institute, involving oxidative stress in the retina.
Home
Our work in RP has led us to also pursue other ocular diseases involving oxidative stress.